Illumina estimated last year that the total addressable market for DNA sequencing was $20 billion, and Illumina's Jay Flatley now tells Luke Timmerman at Forbes that "if you were to ask us what we think it is today, it's substantially bigger."
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
The New York Times Magazine writes that proteomics might be better poised than genomics to say when someone is falling ill.
Bloomberg profiles IndieBio, a startup incubator for the life sciences.
In an editorial, Nature calls for the end to the exploitation of foreign postdocs.
In Nucleic Acids Research this week: collection of epigenome-wide association study data, updated BloodSpot database, and more.